Wyndgate Technologies' Donor Doc is an electronic health history questionnaire and physical exam tracking system intended to assist blood donor centres with screening donors and capturing relevant medical information. This software has been designed to automate screening processes to provide data quality assurance and supporting regulatory compliance. The software is intended to interface with central blood management systems, to allow easy access to donation information, to identify missing or suspect data, to record physical exam results, as well as to capture digital signatures and donor photographs.
This software is also intended to allow donors to self-administer electronic questionnaires at their own pace, with options such as audio or text in their own language and graphics to help convey the meaning of a question.
Donor Doc was designed with significant input from the blood bank industry and Wyndgate customers. The company organized a technology work group consisting of leading industry representatives from around the world during development and beta testing of the software.
Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies, commented: "Global Med Technologies and Wyndgate Technologies are pleased to have submitted Donor Doc for FDA 510(k) clearance. We continue to strive to deliver products that our customers request and need. We appreciate the contributions of our customers to all of our products, and we are confident in the quality and functionality of Donor Doc. Our technology work group has been invaluable throughout this process, and we thank them. We look forward to the response from the FDA regarding clearance for Donor Doc."
CMH is replacing and upgrading the information system in its transfusion service following its current vendor's decision to discontinue support for their system. After evaluating several systems, CMH made the decision that SafeTrace Tx offered the specific capabilities needed to support the hospital's current and future growth.
"Deciding to move away from our previous vendor was significant, since we had worked with them for many years. However, during our evaluation process, we found that Wyndgate's SafeTrace Tx system offered a number of advantageous features. These features include better compatibility with our existing IT infrastructure, a number of beneficial safety features, fast and easy access to important patient information through Wyndgate's Patient-At-A-Glance Bar, and ISBT 128 blood labeling capabilities", stated Clayton Johnson, Laboratory Director at CMH.
"We plan to move to the ISBT 128 standard this coming fall and our transfusion service has grown considerably since expanding the hospital's cancer care with the recent purchase of a linear accelerator", Mr. Johnson continued. "We believe that the SafeTrace Tx system can grow with us. We look forward to implementing the system in the hospital and using it to provide the best advantage to our physicians and patients."
"Caldwell Memorial Hospital is committed to meeting the health needs of its community with high-quality care and the best medical technology available. It is an honour to have been selected by such an upstanding hospital. We look forward to working with the hospital's staff and providing them with the best quality products and services we can offer", responded Noah Bentley Sr., Director of Marketing at Wyndgate Technologies.
Caldwell Memorial Hospital is the private, not-for-profit, community hospital located in Lenoir, North Carolina. The mission of Caldwell Memorial Hospital is to provide safe, effective, compassionate care and to promote healthy lifestyles to its community.
Global Med Technologies Inc. is an international e-Health medical information technology company providing information management software products and services to the health care industry. Its Wyndgate Technologies division is a supplier of information management systems to United States and international blood centres and hospital transfusion centres. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27 percent of the United States blood supply.
Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the patent pending SafeTrace Tx advanced transfusion management system and the SafeTrace donor management system provide Vein-to-Vein tracking from donor collection to patient transfusion. More company news is available in the VMW December 2006 article Global Med Technologies Inc.'s division, Wyndgate Technologies teams with Hospital Partners of America and Indiana Blood Center.